Navigation Links
Polyclonal Antibody Production from Agro-Bio

ProductsPolyclonal Antibody Production from Agro-Bio
Company Agro-Bio
Item Polyclonal Antibody Production
Price 
Description Conjugated peptides, recombinant or native proteins are used to immunize rabbits.
Agro-Bio has developed an immunization protocol optimized in time, quantity of antigen and quality of the antibodies obtained. We recommend the use of 2 animals per protocol in order to avoid animal variability. The average serum yield on a 77-day protocol is approximately 75 mL per rabbit. 150 to 250 g immunogen is used for each immunization. Schedule: Day 0 : Bleed 2 mL per rabbit (pre-immune serum) Immunize with antigen in Complete Freund's Adjuvant (CFA)
Day 14 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 28 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 42 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 49 : 1st production bleed 20-25 mL
Day 56 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 63 : 2nd production bleed 20-25 mL
Day 77 : 3rd production bleed 20-25 mL

The rabbits can be maintained on a two-week cycle of immunization and bleeds as required by the project.

Additional services:
Peptide synthesis and conjugation
ELISA test
Antibody purification on protein A/G or by affinity on antigen

Chickens are an excellent host for producing antibodies. In most cases high titer polyclonal chicken antibodies can be obtained in one month immunization protocol. Conjugated peptides, recombinant or native proteins are used to immunize chickens.

Schedule:
Day 0: Purified the IgY from 3 pre-immune egg yolk per chicken (serve as negative controls). Immunize with antigen in Complete Freund's Adjuvant (CFA)
Day 10: Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 20: Immunize with antigen in IFA
Day 35: Purified antibody (>90% pure) from 6 immunized egg yolk per chicken

Additional services:
Peptide synthesis and conjugation
ELISA test
Antibody purification by affinity on antigen in order to obtain specific IgY

Conjugated peptides, recombinant or native proteins are used to immunize goat. Agro-Bio has developed an immunization protocol optimized in time, quantity of antigen and quality of the antibodies obtained. The average serum yield on a 77-day protocol is approximately 300 mL per goat. 150 to 250 g immunogen is used for each immunization (5 immunizations/ goat with a 77-days protocol).

Schedule:
Day 0 : Pre-immunization bleed Immunize with antigen in Complete Freund's Adjuvant (CFA)
Day 14 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 28 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 42 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 56 : 1st production bleed 150 mL
Day 63 : Immunize with antigen in Incomplete Freund's Adjuvant (IFA)
Day 77 : 2nd production bleed 150 mL

Goat can be maintained on a three-week cycle of immunization and bleeds as required by the project.

Additional services:
Peptide synthesis and conjugation
ELISA test
Antibody purification on protein A/G or by affinity on antigen

Info Agro-BioAgro-Bio
La Chavannerie
Rue Denis Papin
45 240 La Fert St Aubin
Customer Service: +33 (0)2 38 64 83 50
Fax Number: +33 (0)2 38 64 83 59
Web Site: http://www.agro-bio.fr
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Goat Anti-TGase3 (S-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
2. Rabbit Anti-Aph-1aL, S Loop (92-115) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc
3. Goat Anti-SCCRO (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
4. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
5. Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
6. Goat Anti-XPLAC (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
7. Anti-JIP 1 / 2 (SH3) Polyclonal Antibody, Unconjugated, Clone ZMD.177 from Invitrogen
8. Rabbit Anti-Human Sirtuin (silent mating type information regulation 2, S.cerevisiae, homolog) 7 (SIRT7) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
9. Goat Anti-Human RORgamma (S-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
10. Rabbit Anti-Esa1 Polyclonal Antibody, Unconjugated from Abcam
11. Rabbit Anti-Human Rad51 Polyclonal Antibody, Unconjugated from Abcam
For microscopy...
... fully automated hybridization of microarrays on slides. ... designed to offer researchers improved reproducibility, superior ... a wide range of applications. Incubations ... denaturations of up to 99C. The possibility ...
... slide processing offering reproducibility, reliability and ... miniaturization, automation and massive parallel analysis ... with many applications in both industrial ... from gene expression profiling, gene regulation ...
... Eppendorf Thermomixer R offers maximum application ... shaking, heating, and cooling. Its active ... application and temperature control ranges. Five ... 24 micro test tubes, are available ...
Biology Products:
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/7/2015)... 30, 2015 Research ... addition of the "Capacitive Fingerprint Sensors Patent ... To this date, fingerprint sensing technology is the ... sensors are well developed. This patent landscape focuses ... The domain of capacitive fingerprint sensors is ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... Researchers from the Institute of Food Research and The ... a gut bacterium, to help understand how these organisms ... relationship between gut bacteria and the gastrointestinal tract is ... the role of bacteria in establishing and maintaining gut ...
... , Higher temperatures could significantly impact California and other ... next 30 years, according to a new study led ... June 30 edition of Environmental Research Letters , ... land suitable for cultivating premium wine grapes in high-value ...
... BALTIMORE, June 29, 2011 BD Biosciences, a ... today the availability of BD Recharge™, a chemically ... manufacturing that offers productivity comparable to yeast-based peptones. ... significant advance for biopharmaceutical cell culture," said Robert ...
Cached Biology News:Genome analysis will reveal how bacteria in our guts make themselves at home 2Global warming could alter the US premium wine industry in 30 years, says Stanford study 2Global warming could alter the US premium wine industry in 30 years, says Stanford study 3Global warming could alter the US premium wine industry in 30 years, says Stanford study 4BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production 2
(Date:7/29/2015)... / Japan (Q2 2015: +14% CER / ... on high-single-digit growth in China , as well as solid ... . Europe / Middle East ... sales) showed gains in Germany , Turkey ... +4% CER / 49% of sales) grew 11%, excluding U.S. HPV sales, on ...
(Date:7/29/2015)... Research and Markets ... the "Global Biosimilars Market, 2015 - 2025" ... Global Biosimilars Market, 2015 - 2025, report provides ... market. With the blockbuster biologics losing patent protection ... are being viewed as viable substitutes to the ...
(Date:7/29/2015)... -- Indivior PLC (LON: INDV) today announced that the New ... and received Priority Review by the U.S. Food and ... This naloxone nasal spray comes as a pre-filled device ... the nasal mucosa. 1 The device has been ... better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi LifeSciences™ formalized ... specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and ... PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical ...
Breaking Biology Technology:QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3